{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:03:03Z","timestamp":1747202583012,"version":"3.40.5"},"reference-count":18,"publisher":"Ordem dos Medicos","issue":"5","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Med Port"],"abstract":"<jats:p>O priapismo pode ser um efeito adverso das heparinas de baixo peso molecular, cuja fisiopatologia n\u00e3o \u00e9 totalmente compreendida. Os autores apresentam o caso de um doente, do sexo masculino, 51 anos, com diagn\u00f3stico de oligodendroglioma. O doente apresentou um epis\u00f3dio de priapismo, no terceiro m\u00eas sob tinzaparina, sem nenhuma outra altera\u00e7\u00e3o recente da sua medica\u00e7\u00e3o habitual e com consumo de outros medicamentos negado. Foi submetido a cirurgia, com resolu\u00e7\u00e3o do priapismo, mas apresentou fibrose sequelar dos corpos cavernosos, com consequente disfun\u00e7\u00e3o er\u00e9ctil. Desde ent\u00e3o o doente n\u00e3o retomou heparina e n\u00e3o apresentou novos epis\u00f3dios de priapismo. Um c\u00e9lere reconhecimento do quadro pode contribuir para menores sequelas, com consequente diminui\u00e7\u00e3o da morbilidade e impacto na qualidade de vida. Mais investiga\u00e7\u00e3o \u00e9 necess\u00e1ria para aumentar o conhecimento sobre a fisiopatologia desta situa\u00e7\u00e3o.<\/jats:p>","DOI":"10.20344\/amp.18350","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T13:51:17Z","timestamp":1661781077000},"page":"358-360","source":"Crossref","is-referenced-by-count":1,"title":["Priapismo Secund\u00e1rio a Heparinas de Baixo-Peso-Molecular: Um Caso Cl\u00ednico"],"prefix":"10.20344","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9150-4180","authenticated-orcid":false,"given":"Joana","family":"Liz-Pimenta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-8657","authenticated-orcid":false,"given":"Nuno","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-9237","authenticated-orcid":false,"given":"Miguel","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6482-2973","authenticated-orcid":false,"given":"Marta","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8464","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"3193","doi-asserted-by":"crossref","unstructured":"Anele UA, Le BV, Resar LM, Burnett AL. How I treat priapism. Blood. 2015;125:3551-8.","DOI":"10.1182\/blood-2014-09-551887"},{"key":"3194","doi-asserted-by":"crossref","unstructured":"Berger R, Billups K, Brock G, Broderick GA, Dhabuwala CB, Goldstein I, et al. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impot Res. 2001;13:S39-43.","DOI":"10.1038\/sj.ijir.3900777"},{"key":"3195","doi-asserted-by":"crossref","unstructured":"Scherzer ND, Reddy AG, Le TV, Chernobylsky D, Hellstrom WJ. Unintended consequences: a review of pharmacologically induced priapism. Sex Med Rev. 2019;7:283-92.","DOI":"10.1016\/j.sxmr.2018.09.002"},{"key":"3196","doi-asserted-by":"crossref","unstructured":"Lin PH, Bush RL, Lumsden AB. Low molecular weight heparin induced priapism. J Urol. 2004;172:263.","DOI":"10.1097\/01.ju.0000132155.38285.8e"},{"key":"3197","doi-asserted-by":"crossref","unstructured":"Bick RL, Frenkel EP. Clinical aspects of heparin-induced thrombocytopenia and thrombosis and other side effects of heparin therapy. Clin Appl Thromb Hemost. 1999;5:S7-15.","DOI":"10.1177\/10760296990050S103"},{"key":"3198","doi-asserted-by":"crossref","unstructured":"Carmoi T, Skopinski S, Constans J, Vahedy A, Conri C. Priapisme et h\u00e9parine de bas poids mol\u00e9culaire. A propos d\u2019un cas. Rev Med Interne. 2001;22:1002-3.","DOI":"10.1016\/S0248-8663(01)00464-7"},{"key":"3199","doi-asserted-by":"crossref","unstructured":"Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF. American Urological Association guideline on the management of priapism. J Urol. 2003;170:1318-24.","DOI":"10.1097\/01.ju.0000087608.07371.ca"},{"key":"3200","doi-asserted-by":"crossref","unstructured":"Moik F, Chan WS, Wiedemann S, Hoeller C, Tuchmann F, Aretin MB. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy. Blood. 2021;137:1669-78.","DOI":"10.1182\/blood.2020007878"},{"key":"3201","doi-asserted-by":"crossref","unstructured":"Purnell J, Abdulla AN. Case report: ischemic priapism secondary to tinzaparin. Int J Impot Res. 2018;30:62-4.","DOI":"10.1038\/s41443-017-0008-0"},{"key":"3202","doi-asserted-by":"crossref","unstructured":"Christ GJ, Richards S, Winkler A. Integrative erectile biology: the role of signal transduction and cell-to-cell communication in coordinating corporal smooth muscle tone and penile erection. Int J Impot Res. 1997;9:69-84.","DOI":"10.1038\/sj.ijir.3900277"},{"key":"3203","doi-asserted-by":"crossref","unstructured":"Fournier GR Jr, Juenemann KP, Lue TF, Tanagho EA. Mechanisms of venous occlusion during canine penile erection: an anatomic demonstration. J Urol. 1987;137:163-7.","DOI":"10.1016\/S0022-5347(17)43911-5"},{"key":"3204","doi-asserted-by":"crossref","unstructured":"Song PH, Moon KH. Priapism: current updates in clinical management. Korean J Urol. 2013;54:816.","DOI":"10.4111\/kju.2013.54.12.816"},{"key":"3205","doi-asserted-by":"crossref","unstructured":"Bschleipfer TH, Hauck EW, Diemer TH, Bitzer M, Kirkpatrick CJ, Pust RA. Heparin-induced priapism. Int J Impot Res. 2001;13:357-9.","DOI":"10.1038\/sj.ijir.3900759"},{"key":"3206","doi-asserted-by":"crossref","unstructured":"Duggan ML, Morgan C Jr. Heparin: a cause of priapism? South Med J. 1970;63:1131-4.","DOI":"10.1097\/00007611-197010000-00008"},{"key":"3207","unstructured":"De Siati M, Chierigo P, Contin F, Lazzarotto M, Rahmati M, Franzolin N. Priapism as a complication of heparin therapy. Arch Ital Urol Androl. 1999;71:201-2."},{"key":"3208","doi-asserted-by":"crossref","unstructured":"Burke BJ, Scott GL, Smith PJ, Wakerley GR. Heparin-associated priapism. Postgrad Med J. 1983;59:332-3.","DOI":"10.1136\/pgmj.59.691.332"},{"key":"3209","unstructured":"H\u00f8yerup P, Dahl C, Azawi NH. Partiel priapisme. Ugeskr Laeger. 2014;176: V11130680."},{"key":"3210","doi-asserted-by":"crossref","unstructured":"Gresty H, Tadtayev S, Arumainayagam N, Patel S, King C, Boustead G. Quantitative functional outcomes of the conservative management of partial segmental thrombosis of the corpus cavernosum. Ann R Coll Surg Engl. 2015;97:e108-11.","DOI":"10.1308\/rcsann.2015.0026"}],"container-title":["Acta M\u00e9dica Portuguesa"],"original-title":[],"link":[{"URL":"https:\/\/www.actamedicaportuguesa.com\/revista\/index.php\/amp\/article\/download\/18350\/6748","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.actamedicaportuguesa.com\/revista\/index.php\/amp\/article\/download\/18350\/6748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T14:29:14Z","timestamp":1744900154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.actamedicaportuguesa.com\/revista\/index.php\/amp\/article\/view\/18350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,2]]}},"URL":"https:\/\/doi.org\/10.20344\/amp.18350","relation":{},"ISSN":["1646-0758","0870-399X"],"issn-type":[{"type":"electronic","value":"1646-0758"},{"type":"print","value":"0870-399X"}],"subject":[],"published":{"date-parts":[[2022,8,29]]}}}